
Corporate ActionNov 5, 2026, 08:11 AM
Avalo Therapeutics Launches $200M At-The-Market Offering with Jefferies
AI Summary
Avalo Therapeutics, Inc. has entered into an Open Market Sale Agreement with Jefferies LLC, establishing an "at-the-market" offering program. Under this agreement, Avalo can issue and sell shares of its common stock, with an aggregate offering price of up to $200,000,000, through Jefferies as the sales agent. Jefferies will receive a commission of up to 3.0% of the gross proceeds. Concurrently, Avalo has terminated its prior Sales Agreement with TD Securities (USA) LLC.
Key Highlights
- Avalo Therapeutics entered into an Open Market Sale Agreement with Jefferies LLC for an at-the-market offering program.
- The program allows Avalo to issue and sell shares of common stock through Jefferies.
- The aggregate offering price for the shares is up to $200,000,000.
- Avalo will pay Jefferies a commission of up to 3.0% of the gross proceeds from any shares sold.
- The company terminated its previous Sales Agreement with TD Securities (USA) LLC, effective immediately.
Price Impact
More from AVTX